GUARDANT HEALTH INC

Guardant Health insiders trade on Sept 17, 2026—buyers show long‑term confidence while sellers balance liquidity, underscoring the company’s precision‑medicine growth strategy.

Guardant Health insider sales trend: CTO’s recent 7,738‑share sell‑off reflects routine vesting, not a company shift, amid rising stock and social‑media buzz.

Guardant Health insider Azar Alex M II buys and converts shares, signaling confidence in the company’s liquid‑biopsy platform and near‑term value.